Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis
CompanyDeals

Adaptive Licenses TCR Data to Pfizer in $890M Deal for Rheumatoid Arthritis

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline
CompanyDrug

Hengrui NMPA Approves Four Clinical Trials Advancing Oncology and Metabolic Pipeline

GSK's Nucala Wins CHMP Nod for COPD in Europe
CompanyDrug

GSK’s Nucala Wins CHMP Nod for COPD in Europe

Sobi Acquires Arthrosi for $1.5 Billion to Add Gout Drug to Portfolio
CompanyDeals

Sobi Acquires Arthrosi for $1.5 Billion to Add Gout Drug to Portfolio

Novo Nordisk's Wegovy 7.2mg Gets EMA Positive Opinion for Obesity
CompanyDrug

Novo Nordisk’s Wegovy 7.2mg Gets EMA Positive Opinion for Obesity

Innovent's Mazdutide Wins Macau Approval for Weight Management
CompanyDrug

Innovent’s Mazdutide Wins Macau Approval for Weight Management

Kyinno Biotechnology Closes RMB 250M Series B for Bispecific Antibody Pipeline
CompanyDeals

Kyinno Biotechnology Closes RMB 250M Series B for Bispecific Antibody Pipeline

Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing
CompanyDeals

Cellular Origins Raises $40M Series A Led by Johnson & Johnson for Cell Therapy Manufacturing

Akeso's Cadonilimab Wins FDA Nod for Global Phase 3 Gastric Cancer Study
CompanyDrug

Akeso’s Cadonilimab Wins FDA Nod for Global Phase 3 Gastric Cancer Study

China Healthcare Fund Settlement Reform Targets 3% Ratio by 2028
Policy / Regulatory

China Healthcare Fund Settlement Reform Targets 3% Ratio by 2028

Junshi Biosciences Wins FDA Nod for EGFR/HER3 Bispecific ADC in Solid Tumors
CompanyDrug

Junshi Biosciences Wins FDA Nod for EGFR/HER3 Bispecific ADC in Solid Tumors

Henlius Serplulimab NDA Wins Priority Review for Gastric Cancer as Adjuvant Therapy
CompanyDrug

Henlius Serplulimab NDA Wins Priority Review for Gastric Cancer as Adjuvant Therapy